Equitec Proprietary Markets’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Equitec Proprietary Markets’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-164,100	Closed	-$2.78M	–	673
2014 Q4	$2.78M	Buy	+164,100	New	+$2.31M	0.12%	39

Equitec Proprietary Markets's AVNR Position: Q1 2015 in Review

Equitec Proprietary Markets sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 164,100 shares — an estimated $2.78M sold.

Equitec Proprietary Markets first reported a position in AVNR in Q4 2014 and held it in 1 quarter. The position peaked at $2.78M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

Equitec Proprietary Markets reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
Equitec Proprietary Markets sold 164,100 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $2.78M.
Equitec Proprietary Markets first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q4 2014 and held it in 1 quarter.
Equitec Proprietary Markets's AVANIR PHARMACEUTICALS, INC CL A position peaked at $2.78M in Q4 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Equitec Proprietary Markets's 13F filing for Q1 2015, filed 7 May 2015.